高度近视眼年龄相关性黄斑变性的患病率与表型
在五个视网膜三级转诊中心纳入442例55岁以上高度近视(眼轴≥25.5 mm)患者,估计该人群AMD频率为11.9%(95%CI 9.8%-14.0%)。104眼中新生血管检出52眼(50%),以1型最常见(39眼,75%);基线未治疗新生血管眼第一年需3.8±1.5次抗VEGF注射,超过单纯高度近视人群的1.8至3.6次。
要点
- 55岁以上高度近视患者AMD估计频率为11.9%(95%CI 9.8%-14.0%)。
- 104眼中新生血管52眼(50%),1型39眼(75%)最常见。
- 高度近视合并AMD的新生血管眼第一年注射次数超过无AMD的高度近视眼。
核心结论
- 研究提示高龄高度近视患者发生干性和新生血管性AMD的风险显著。
- 高度近视合并AMD眼的新生血管第一年所需注射次数多于无AMD的高度近视眼。
研究设计与样本
- 在五个视网膜三级转诊中心识别高度近视患者。
- 纳入标准为年龄55岁及以上、眼轴长度≥25.5 mm的高度近视患者。
- 共识别442例55岁以上高度近视患者的874眼,最终纳入54例患者的104眼,年龄72±11岁,随访23.5±19.5个月。
主要发现
- 55岁以上高度近视受试者中估计AMD频率为11.9%(95%CI 9.8%-14.0%)。
- 104眼中34眼诊断玻璃膜疣,22眼诊断网状假性玻璃膜疣(RPD),28眼同时有玻璃膜疣和RPD,20眼诊断地图样萎缩。
- 52眼(50%)检出新生血管,其中1型39眼(75%)最常见。
- 新生血管总体接受抗VEGF注射4.6±2.6次;基线未治疗新生血管眼(n=34)治疗第一年需3.8±1.5次注射。
- 基线未治疗新生血管眼第一年注射次数超过单纯高度近视人群的1.8至3.6次。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze the frequency and phenotypic variation of AMD in subjects with high myopia (HM), and to describe the clinical course and response to treatment of neovascularization (NV). METHODS: Patients with HM were identified at five retina tertiary referral centers. Inclusion criteria were myopic patients aged 55 years or more with axial lengths equal or greater than 25.5 mm. RESULTS: A total of 874 eyes from 442 HM subjects older than 55 years were identified and 104 eyes of 54 patients (72 ± 11 years) were included in the study and followed up for 23.5 ± 19.5 months. The estimated AMD frequency in HM subjects over 55 years was 11.9% (95% confidence interval; 9.8%-14.0%). A total of 34 of 104 eyes were diagnosed with drusen, 22 with reticular pseudodrusen (RPD), 28 with both drusen and RPD, and 20 with geographic atrophy. Neovascularization was detected in 52 eyes (50%), and type 1 was the most frequent form (39 eyes, 75%). Overall, NV was treated with 4.6 ± 2.6 anti-VEGF injections. Eyes with treatment-naïve NV at baseline (n = 34) required 3.8 ± 1.5 anti-VEGF injections during the first year of treatment. This exceeded the injection number in the purely myopic population (1.8 to 3.6 injections for the first year). CONCLUSIONS: This study provides evidence to suggest that older patients with HM are at a significant risk of the dry and neovascular forms of AMD. NV in eyes with HM and AMD required more injections in the first year compared to NV in HM eyes without AMD.
引用
- Corbelli E, Parravano M, Sacconi R, et al. Prevalence and Phenotypes of Age-Related Macular Degeneration in Eyes With High Myopia. Invest Ophthalmol Vis Sci. 2019. PMID: 30938774. doi:10.1167/iovs.18-25534
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。